Carlsbad, California, United States POSCO BioVentures appeared to be the VC, which was created in 2002. The main office of represented VC is situated in the Carlsbad. The company was established in North America in United States.
The usual cause for the fund is to invest in rounds with 7 partakers. Despite the POSCO BioVentures, startups are often financed by Alta Partners, Sherbrooke Capital, Flagship Pioneering. The meaningful sponsors for the fund in investment in the same round are Sherbrooke Capital, HealthCap, Flagship Pioneering. In the next rounds fund is usually obtained by Novo Holdings, Inventages Venture Capital Investment Inc., Flagship Pioneering.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Pulmonx, Nucleonics, Archemix Among the most popular fund investment industries, there are Life Science, Therapeutics. The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Besides them, we counted 2 critical employees of this fund in our database.
The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2019. The top activity for fund was in 2004. Considering the real fund results, this VC is 13 percentage points less often commits exit comparing to other organizations. Opposing the other organizations, this POSCO BioVentures works on 2 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Admiral Capital Group | New York, New York, United States |
| Bluestem Capital | Sioux Falls, South Dakota, United States |
| China Everbright Investment Management | China, Hong Kong, Hong Kong Island |
| Cyberbond | Chiyoda, Japan |
| GKN | Redditch, United Kingdom, Worcestershire |
| Guokun Investment | China, Jiangsu, Nanjing |
| Hansol PNS | Seoul, Seoul-t'ukpyolsi, South Korea |
| Huaqing Capital | China, Guangdong, Shenzhen |
| Jolimont Capital | Australia, Melbourne, Victoria |
| LG Innovation Ventures | California, San Jose, United States |
| Liberty Mutual Insurance | Boston, Massachusetts, United States |
| Lynx Technology Partners | New York, New York, United States |
| NETOPIA | Bucharest, Bucuresti, Romania |
| Oxford Blackpoint Venture Partners | Chicago, Illinois, United States |
| Ricebank | China, Hangzhou, Zhejiang |
| ScaleUp Capital | - |
| Shenzhenshi Jiruihe Guquan Touzi | China, Guangdong, Shenzhen |
| Voxx Electronics | Florida, Lake Mary, United States |
| Zongton Capital | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Pulmonx | $32M | 08 Mar 2010 | Redwood City, California, United States | ||
Accera | $35M | 12 Nov 2008 | Broomfield, Colorado, United States | ||
TransMedics | $29M | 14 Mar 2006 | Massachusetts, United States | ||
ProteinSimple | $27M | 01 Jan 2006 | San Jose, California, United States | ||
GeneOhm Sciences | $14M | 18 Jan 2005 | San Diego, California, United States | ||
Accera | $6M | 16 Sep 2004 | Broomfield, Colorado, United States | ||
Eyebright plc | $49M | 02 Jun 2004 | Pennsylvania, United States | ||
Archemix | $50M | 07 Apr 2004 | San Francisco, California, United States | ||
TransMolecular | $33M | 01 Mar 2004 | Birmingham, Alabama, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Pulmonx | $32M | 08 Mar 2010 | Redwood City, California, United States | ||
Accera | $35M | 12 Nov 2008 | Broomfield, Colorado, United States | ||
TransMedics | $29M | 14 Mar 2006 | Massachusetts, United States | ||
ProteinSimple | $27M | 01 Jan 2006 | San Jose, California, United States | ||
GeneOhm Sciences | $14M | 18 Jan 2005 | San Diego, California, United States | ||
Accera | $6M | 16 Sep 2004 | Broomfield, Colorado, United States | ||
Eyebright plc | $49M | 02 Jun 2004 | Pennsylvania, United States | ||
Archemix | $50M | 07 Apr 2004 | San Francisco, California, United States | ||
TransMolecular | $33M | 01 Mar 2004 | Birmingham, Alabama, United States |
